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x 
An enzyme immunoassay specific for several B-lactam antibiotics 
rather than individual antibiotics was investigated. The goal to 
develop an enzyme immunoassay for analysis of a whole class of 
compounds at one time is different than the goal of most enzyme 
immunoassays which des i re specificity for drugs or hormone levels. 
Detection of t he presence of all B-lactam antibiotics is wanted and 
. 
identification of specific antibiotics is not needed. 
6-Aminopenicillanic acid, the common structural moiety of 
B- l actam antibiotics was used tin this investigation. Methods of 
preparation of 6-aminopencillanic ac id conjugates 2nd antibodies 
needed for enzyme immun oassays have been developed. 
6-Aminopenicillanic acid was conjugated to ovalbumin and bovine gamma 
globulin for production of antibodies with specificity to 
6-aminopenicillanic acid. 6-Aminopenicillanic acid was also linked to 
the enzyme· horseradish peroxidase for future use in enzyme 
immun oassays. 
xi 
Antibodies produced against 6-aminopenicillanic acid are 
antigenic towards the thiazolidine ring of penicillins as shown by 
their affinity to ampicillin and penicillin . Anti-6-aminopenicillanic 
acid antibodies should therefore be antigenic towards other 
semisynthetic penicillins because 6-aminopenicillanic acid is usually 
used in their synthesis. 
(79 pages) 
INTRODUCTION 
Antibiotics are used for treatment of bacterial mastitis in dairy 
cows. Residual antibiotics in milk may induce allergic response in 
susceptible individuals causing a public health hazard. Antibiotics 
also cause financial losses for both farmers and milk processors by 
inhibiting the growth of lactic microorganisms in dairy products. An 
estimated 20 million dollars per year is spent by the U. S. dairy 
industry to test for and discard contaminated milk (Ryan, 1983). In 
addition, contaminated market milk exposes consumers and the 
environment to low levels of antibiotics and enhances the development 
of antibiotic-resistant pathogenic bacterial strains. 
The most freq uentl y used B-lactam antibiotics in mastitis 
preparations (Figure l) are penicillin-G, ampicillin, cloxacillin and 
cephapirin (Herbst, 1982). Penicillin-G is the most common ly used of 
all antibiotics (Macaulay and Packard, 1981). The Food and Drug 
Administration standard for antibiotics in milk is zero-tolerance 
(Kornfeld, 1977). Presence of any penicillin in milk constitutes 
adulteration . 
Several microbial and nonmicrobial assays exist for detection of 
antibiotics in milk, but it is desired that a rapid and affordable 
method for an on -the-farm use be developed. Enzyme immu noassay for 
B-lactam anti biotics could possibly be used to achieve this goal. 
Preliminary aspects for development of such an assay have been 
studied. An immunoassay specific for several B-lactam antibiotics 
rather than individual antibiotics was investigated. 
6-Amin openicillan ic acid (APA), the common structural moiety of all 
2 
B-lactam antibiotics (Figure 1 ) , was linked to a protein carrier for 
production of antibodies. Crossreactivity of anti-APA antibodies with 
B-lactam antibiotics was shown. APA is used for the synthesis of many 
semisynthetic B-lactam antibiotics, therefore anti-APA antibodies 
should be antigenic to those antibiotics. 
3 
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Chemical structures of a) penicillin-G, b) ampicillin, 
c) cephapirin, d) cloxacillin and e) 6-aminopenicillanic 
acid. 
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REVIEW OF LITERATURE 
Occurrence of Antibiotic Contaminated Milk 
Antibiotics may be present in milk after treatment of dairy cows. 
Undetected antibiotics in milk present problems for dairies that 
attempt to utilize the milk for cultured dairy products. This is due 
to inhibition of the culture microorganisms. Mastitis is a costly 
disease for the dairy industry, and has led to the use of antibiotics 
for treating affected animals. Mastitic milk and milk following 
antibiotic treatment must be disposed of, thus decreasing production. 
Occurrence of mastitis is high during the first stages of lactation 
then decreases until the drying off period when the incidence of 
mastitis ~ncreases dramat~cally (Natzke, 1981 ). This has led to the 
practice of dry therapy where all cows are given antibiotic treatments 
to reduce the incidence of mastitis within the herd. 
Penicillin is the most commonly used antibiotic for treatment of 
mastitis. Approxi~ately ninety percent of antibiotic products contain 
penicillin alone or in combination with other antimicrobial agents 
(Macaulay and Packard, 1981). Manufacturers of antibiotic 
preparations recommend withholding milk from treated cows after the 
last injections of antibiotics . Withholding times vary between 
manufacturers, antib i otic preparations and types of treatment, i.e ., 
intramammary and intramuscular injections (Freke and Bates, 1981; 
Johnson et al. , 1977). The occurrence of antib iotic contaminated milk 
and laboratory studies indicate that statutory withholding times 
should be a minimum standard and not the on ly criteria for forwarding 
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milk. Secretion of antibiotics varies between animals and is affected 
by the bases and preservatives added to the antibiotic preparations. 
Detection of Antibiotics 
New methods for detecting of antibiotics and improving old 
methods are continually being investigated. The ultimate goal is to 
develop a rapid and sensitive method to detect residual antibiotics at 
minimal cost. There are three major classes of methods for antibiotic 
detection: microbial, non -microbial, and dye marking. The microbial 
methods are most commonly used. Table l is a summary of 
characteristics of available penicillin assays. 
Micobial Assays 
Standard Methods for the Examination of Dairy Products (Marth, 
1978) describes three methods for dete cting of antibiotic residues in 
milk: (l) Bacillus subtilis disc assay; (2) Modified Sarcina ]utea 
cylinder plate method; and (3) specific antimicrobial cylinder methods 
(Marth, 1978). Since publication of Standard Methods for the 
Examination of Dairy Products several procedures with improved 
sensitivities have been defined. 
The Bacillus subtilus disc assay is the assay specified by the 
Association of Official Analytical Chemists (AOAC) (Kaufman, 1977). 
Spores of B. subtilus are incorporated into the seed agar. Sterili zed 
paper discs which have been dipped in a standard solution of 
antibiotics and discs saturated with milk are placed on the agar 
surface. The plates are incuba ted at 32°C for 14-24 h. Presence 
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Table l. Comparison of characteristics of available antibiotic tests. 
Assay 
Disc Assay 
(Bacillus subtilus) 
Cylinder Method 
(Sarcina lutea) 
Disc Assay 
Penicillin 
Sensitivity (IU/ml) 
O.Q.5a 
O.Olb 
(Sarcina lutea w/lysozyme) 0.0075c 
Delvotest P Kits 
( B. stearothermo hilus 
0.0084d var. calidolactics 
Di fco Disc Assay .005d 
Charm Test e 0 .001 f 
0.01-.005 
Penzyme Assay 0.008-0.0099 
Spot Test o.008-o.009h 
a Kaufman, 1977 
Time 
14-24 h 
14-24 h 
14-24 h 
2.5 h 
14-24 h 
7-30 min 
20 min 
6 min 
bJohnson et al., 1977; Kornfeld, 1977 
c Johnson et al., 1977; Macaulay and Packard, 1981; Van O's and 
Beukers, 
1980. 
dGinn et al., 1978; Macaulay and Packard, 1981. 
eCharm, l980a 
f Macaulay and Packard, 1981 
9smithkline Beckman, 
1984 
hAngenics, 1984 
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of an inhibitory substance causes a zone of clearing around the discs. 
The sensitivity of the assay for penicillin is 0.05 I.U./ml. 
Sarcina lutea is another indicator organism commonly used for 
microbial plate assays (Marth, 1978). Agar is seeded with a supension 
of S. lutea. The cylinder method is usually used with this organism , 
but the disc method also may be employed. Stainless stee l cylinders 
(8 . 0 mm O.D . X 10 mm) are placed onto the agar, and are filled with 
the sample to be tested. The plates are incubated at 32°C overnight. 
Presence of antibiotic in the sample inhibits the growth of S. lutea, 
causing a zone of clearing around the cylinder. The literature 
reports various values for the·penicillin sensitivity of the assay, 
but is generally sensitive down to 0.01 I.U./ml (Johnson et al., 1977; 
Kornfe ld, 1977). 
Lysozyme incorporated into the seed agar of S. lutea enhances the 
sensitivity of the test to 0.0075 I.U. pencillin/ml. (Kornfeld , 1977). 
Addition of lysozyme increases the zone of inhibition and also 
increases its transparency. Dilution of standards with milk decreases 
the size of the zo ne areas. This is believed to result from binding 
of some penicillin to milk proteins which decreases the amount of free 
penicillin in the sample. Both factors affected by addition of 
lysozyme enhance the detectability of antibiotics in milk. It is 
proposed that lysozyme enhances lysis after the action of penicillin 
on the cell wall. At low concentration of penicillin a distinct zone 
of clearing is not noted, but addition of a glycosidase causes 
increased lysis due to weakening of the cell wall. The S. lutea 
8 
cylinder method is more sensitive t han the disc method, but requires 
more equipment and time to perform. 
Bacillus stearothermophilus var. calidolactis is very sensitive 
to a variety of antibiotics. New methods to store and propogate 
spores have allowed incorporation of this organism into antibiotic 
assays. The Delvotest P and Delvotest P mu ltiassays use~ 
stearothermophilis var. calidolactis as the indicator organism 
(Huhtanen et al., 1977; Johnson et al., 1977; Macaulay and Packard, 
1981; Van Os and Beukers, 1980). This test has the highest 
sen sitivity to penicillin of all the microbiological assays and can 
also detect fourteen other antibiotics: cloxacillin, nafcillin, 
ampicillin, tetracycline, oxytetracycline, chlortetracycline, 
chloramphenicol, dihydrostreptomycin, neomycin, kanarnycin, gentarnycin, 
oleandomycin, rifamycin, and erythromycin (Van Os and Beukers, 1980) . 
Delvotest P kits are commercia lly available. A 0. 1 ml milk 
sample and a nutrient tablet are placed in an ampul containing 0.3 ml 
plain agar inoculated with 106 stabilized spores of the indicator 
organism. The agar also contains a pH i ndica tor, bromcresol purple. 
The ampul is incubated in a water bath at 64 °C for 2.5 h. A sample 
containing an inhibitory substance prevents growth of the spores and 
the agar remains purple. Growth of the spores causes a decrease in pH 
and the media turns yellow. An incomplete color change indicates a 
false-positive result and occurs at low antibiotic concentrations. 
The Delvotest is more sensitive than pre viously mentioned 
microbial tests and requires only a 2.5 h incubation period. 
Penicillin concentrations greater than 0 .0084 I.U./ml are detected 
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with 100% accuracy. Lower concentrations increase the occurrence of 
false - positive tests. In this range (0.002 - 0.004 I.U . /ml ) , 
penicillin does not inhibit lactic culture growth, but false-positive 
tests should be treated as positive because the lower limit of human 
hypersensitivity is not known. 
The Difeo disc assay is another commercially available antibiotic 
test which uses B. stearothermophilus var. calidolactis as the 
indicator organism (Ginn et al., 1978; Macaulay and Packard, 1981). 
The Difeo disc assay is more sensitive than the S. lutea and B. 
subtilis disc assays. Bromocresol purple is incorporated in the seed 
agar. A positive test results in a color change and a zone of 
inhibition. The sensitivity to penicillin has been reported as 0.005 
I.U. / ml with 100% accuracy (Macaulay and Packard, 1981 ). Values for 
penicillin sensitivity as low as 0.002 - 0. 004 I.U./ml have been 
recorded (Ginn et al., 1978). The sensitivity of the test decreases 
with the age of the agar plate used. 
All the microbiological tests can be quantitated by use of 
standards. A standard curve for each test can be determined by a 
series of assays of samples with known concentrations of antibiotics . 
All the methods are more sensitive to penicillin than to other 
ant ib iotics, but the assays will detect other antibiotics which 
inhibit their indicator organisms. Microbial assays use penicillinase 
to identify penicillin as the inhibitory substance. 
l 0 
Non-Microbial Tests 
Direct assays for residual antibiotics using non -microbial 
methods are less common than microbial assays, but they may prove to 
be more sensitive. Three such assays are now commercially available: 
the Charm Test (Penicillin, Inc., Boston, MA), Penzyme (Smithkline 
Beckman Co., West Chester, PA) and the Spot test (Angenics, Cambridge, 
MA). The Spot test and Penzyme assay have become available within the 
past year so comparative data for these tests are not available. 
The Charm test is a non-microbial assay specific for detection of 
penicillin (C harm, 1980a; Charm, l980b). Penicillin-sensitive cells 
(lyophilized ~· stearothermophilus) and c14 labelled penicillin are 
added to samp l es. Labelled and free pencillin compete for receptor 
sites on the cell walls. Cel ls are removed by centrifugation. The 
precipitate is washed and the amount of c14 labelled penicillin 
present is determined by counting radioactive emissions. The amount 
of labelled penicillin detected is inversely proportional to the 
amount of free penicillin in the sample. This test is rapid, 
requiring less than 30 min. The initial investment for the centrifuge 
and Geiger cou nter required is substantial, and expense of each assay 
is greater than for microbial tests. Proper procedure for disposal of 
radioactive wastes is required. In comparison with microbial assay 
standards, 15.6% of samples tested by the Charm test were classified 
incorrectly (Thorogood et al., 1983). Precision of the test al so 
decreased with age of the reagents. Daily standard curves would 
increase precision, but also increase time and expense. 
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The Penzyme assay is based on inhibition of 
0-ala -ca rboxypeptidase by bi nding of S- lactam antibiotics at its 
active site (Laloux et al ., 1982 ; Smithkline Beckman, 1984). 
Carboxypeptidase is a penicillin - binding protein i so l ated from some 
species of bacteria. In the i nitial step of the assay , enzyme is 
incubated with milk for 5 min. Penicillin in t he sample partially or 
completely inhibits carboxypeptidase . Substrate 
(Ac-L-lys-O-ala-0-ala) and another enzyme system (0 - arnino oxidase , 
fla vin adenine dinucleotide, perox i dase , and o-dian i sidine) are added 
and incubated at 47°C for 15 min. Carboxypeptidase releases 0-ala 
from the substrate . 0-ala is con verted to pyruvate and hydrogen 
peroxide . In the presence of peroxidase and hydrogen peroxide, 
reduced o-dian isidine is oxidized. Addition of sulfuri c acid results 
in a colored product. Fifty micro liters of milk containing greater 
than 0.0 17 I.U. ant ibi otics per ml will totally inhibit the reaction. 
A semiquantitative est imate of B-lac tams in the range of 0.008 -0 .009 
I . U. /ml can al so be determined. 
Enzyme linked immunoassays (ELISA) have been developed for 
detection of penicil lin in milk , and one vers ion of the assay is 
available commercially from Angenics, Inc. (Brown and Swaisgood, 1982; 
Miura et al., 1981; Ryan, 1983 ) . ELISA provides a rapid method to 
detect penicillin, but like the Charm test, this assay is specific 
only for penicillin. Other ant ibiotics are not detected. 
The Spot test utilizes monoclonal antibodies to detect 
pen icillin-G and cephapirin, a synthetic cepholosporin. Antibiotics 
are bound to latex particles. Reagen ts and milk are mixed en a glass 
l 2 
slide. If no antibiotics (penicillin or cephapirin) are present in 
the test sample, interaction of the antibodies with bound antibiotics 
causes the latex particles to cluster. Within 4 min uncontaminated 
samples develop a grainy appearance and samples with antibiotics 
appear smooth. Free antibiotics bind antibodies and thereby prevent 
agglutination of the latex particles. The total time for the Spot 
Test is 6 min. 
A sandwich ELISA for detection of ampicillin in milk has been 
reported (Miura et al., 1981). Ampicillin concentrations as low as 
0. 01 µg/ml can be detected. s-D-galactosidase is used as the enzyme 
label with 7- s-D galactopyransyloxy-4-methylcoumarin as its substrate. 
The activity of the enzyme label was measured by fluorescence 
intensities. 
An ELISA for penicillin has been reported by Brown and Swaisgood 
(1982). Penicillin concentrations of 0.01-0 . 05 I.U./ml were detected. 
Horseradish peroxidase was used as the enzyme label. Using 
m-phenylenediamine and hyarogen peroxide as co-substrates the 
enzymatic reaction can be followed spectrophotometrically or visually. 
This assay is a competitive immunoassay and activity of the enzyme is 
inversely proportional to penicillin concentration. 
Dye-Infusion Methods 
Add ition of dye to antibiotic preparations used for mastitis 
treatments is the only indirect method used for detecting antibiotics 
(Macintosh and Vilim, 1977; Van Os, 1978). Brilliant Blue F.C.F. is 
added to antibi ot ic preparations. The rate of excretion of dye 
parallels the excretion rate of penicillin. It is only app l icable if 
l 3 
intramammary injections are used. The main advantage is that the dye 
is visible in the milk of individual cows. This method is commonly 
used in Australia and New Zealand. Main disadvantages are that the 
rate of excretion of antibiotics can vary and direct controls may be 
ignored. Thus, contamination from non-dye preparations may go 
undetected. 
Enzyme Immunoassays 
The technique of enzyme immunoassays (EIA) has been extensively 
reviewed (Borrebaeck and Mattiasson, 1979; earlier et al., 1981; 
Halbert, 1981; Maggio, 1980; O'Beirne and Cooper, 1979; Pesce et al., 
1981; Schuurs and vanWeeman, 1977; Schuurs and vanWeeman, 1980; and 
Trivers et al ., 1983). Development of EIA began in the early l970's 
as a method to replace radio-isotopes used as labels for radio 
immunoassays (RIA). The basic principles of EIA and RIA are the same, 
but some enzyme labels have an advantage over RIA in that separation 
of bound and free anti~ens is not required, which allows for automated 
systems. EIA reduce equipment cost and also eliminate problems 
associated with use of radio-isotopes. Common acronyms in the 
literature for different types of EIA are: ELISA, enzyme-linked 
immunosorbent assay or enzyme-linked immunospecific assay and EMIT, 
enzyme-multiplied immunoassay technique. EIA are currently used as 
analytical tools for determination of many different substances 
including: drugs, hormones, proteins, and antibodies. Specificity 
and sensitivity of immunoassays are determined by the binding avidity 
of the antibody for a specific ant igen. 
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Heterogeneous EIA 
Heterogeneous EIA require bound antigen to be separated from free 
antigen prior to addition of enzyme substrate. The major advantage of 
separation of bound and free antigens is increased sensitivity by 
eliminating substances in the sample which may alter enzymic activity 
(Bastinani and Wilcox-Thole, 1982; earlier et al., 1981 ) . Enzyme 
activity is inversely proportional to antigen concentration in 
heterogeous EIA. Criteria for enzymes chosen for EIA include high 
specific activity, high rate constants, stability during conjugation, 
pH optimum compatibility with ligand-antibody binding, easily 
detectable product, absence of endogenous activity in sample and low 
cost availability (Guesdon and Avrameas, 1981; Maggio, 1980). Enzymes 
used for heterogeneous EIA include oxidoreductases (horseradish 
peroxidase and glucose oxidase), and hydrolytic enzymes (alkaline 
phosphatase and S-galactosidase). 
Competitive EIA (Figure 2) parallel the principles of RIA. Free 
antige n~ and labeled antigens compete for antibody binding sites. 
Sample containing antigen is added to antibodies bound to a solid 
phase . The bound antibodies are thoroughly rinsed between each step 
to prevent adhesion of any endogenous proteins to the solid support. 
Following incubation with enzyme-labeled hapten, enzyme substrate is 
added. Reactions can be qualitative by visually noting color change 
and quantitative with spectrophotometric methods. 
Sandwich assays are noncompetitive immunoassays. The most common 
types employ labeled and immobilized antibodies. Figure 3 is a 
schematic representation of a typical sandwich assay. It is necessary 
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Figure 2. Schematic of competitive EIA. (A) Elipsoids represent 
haptens binding to antibodies attached to solid support. 
(B) Enzyme-hapten conjugates are bound by antibodies not 
bound to free hapten . (C) Substrate is added and enzymic 
activity is measured by production of product. Enzymatic 
activity is inversely proportional to free hapten concentra-
tion. 
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Figure 3. Schematic of noncompetitive EIA. (A) Ellipsoids represent 
haptens binding to antibodies attached to solid support; 
(B) Antibodies covalently linked to enzymes bind to haptens 
bound to solid support by antibodies; (C) Substrate is 
added and enzymic activity is determined. Hapten, concentra ~ 
tion is proportional to enzyme activity. · 
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that the antigen have two antigenic determinants. Antigen is exposed 
to immobilized antibodies. After rinsing, enzyme labeled antibodies 
are ad ded. Enzyme activity associated with the solid phase is 
determined. The main advantage of sandwich assays is that 
satisfactory results can be obtained without precise adjustment of 
concentrations of reactants (Schall and Tenoso, 1981 ). 
Homogeneous EIA 
Homogeneous enzyme immunoassays do not require separation of 
bound and free label. In classic homogenous assays binding of 
antibody to enzyme-labeled hapten causes activation or inhibition of 
the enzyme (Figure 4). Lysozyme, malate dehydrogenase, and 
glucose-6-phosphate dehydrogenase are enzymes used for homogeneous EIA 
(Bastiani and Wilcox-Thole, 1982). Other designs such as 
substrate -labeled antigen, cofactor-labeled antigen or enzyme -l abeled 
antibody can also alter catalytic rates of enzymes (Bastiani and 
Wilcox-Thole, 1982). The main advantage of homogeneous EIA is the 
plausibility of automa tion. · 
Methods of Protein Conjugation for EIA 
Small molecular weight molecules (haptens) do not illicit 
antigenic response . Production of antibodies to haptens requires that 
they be covalently bo und to macromolec ul es . Also, depending on the 
type of EIA to be used, preparation of enzyme-hapten conjugates of 
antibody-enzyme (protein-protein) conju gates are required. Many 
articles and books have been written on methods of chemical 
mod ificati on of proteins which can be employed to synthesize 
Figure 4. 
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Schematic of homogeneous EIA. Antibodies are attached to a 
solid support. Free haptens (ellipsoids) and hapten-
enzyme conjugates compete for antibody. Antibodies binding 
to hapten-enzyme conjugates alter catalytic activity of the 
enzyme. 
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protein -protein or protein-hapten conjugates (Kabakoff, 1980; Kennedy 
et al., 1976; Glazer et al., 1975; Means and Feeney, 1971). 
Covalent attachment is made via nucleophilic functional groups, 
i.e., amino, imidizole, guanidino, carboxyl, hydroxyl, and phenolic 
side chains, or carbohydrate moieties on proteins and enzymes. A 
general classification of modifing reactions is acylating reagents, 
alkalating reagents, oxidation and reduction reactions and 
electrophilic reactions (Kabakoff, 1980) . Acylating reagents are used 
to couple activated carboxyls with free amino groups and phenolic side 
chains. Deacylation of tyrosine can be achieved by subsequent 
treatment with hydroxylamine. Acetic anhydride, mixed anhydrides and 
N-hydroxysuccinimide esters are commonly used acylating reagents. 
Alkylating reagents, haloacetate derivatives at alkaline pH and 
maleimides at slightly acidic pH are used to modify protein 
sulfhydryls. Maleimides can be used to introduce fluorogenic labels 
into proteins and bismaleimides to crosslink proteins. 
Arylhalides are another group of protein alkylating compounds 
(Kabakoff, 1980). Fluorodinitrobenzene (FONB) and 
trinitrofluorobenzene (TNFB) react with free amino groups at slightly 
alkaline pH. FDNB and TNBS were among the first haptens attached to 
proteins for immunological studies and have been used for model 
stud ies. Protein crosslinking can be achieved using 
difluorodinitrobenzene. Another frequently used reaction is reductive 
alkylation of amino groups with carbonyl compounds using sodium 
borohydride. This two-step reaction couples carbohydrates to proteins 
or haptens to glycoprote ins. 
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Oxidative and reductive reactions are used to reduce disulfide 
bounds in proteins. Non-protein disulfide bonds can be reduced by 
protein sulfhydryls resulting in linkage via cysteine mo iet ies . 
Treatment of amines with sodium nitrite under acidic conditions 
forms diazonium ions which react by electrophilic substitution with 
phenolic and imidazol protein side chains , and to a lesser extent with 
lysine. Optimum pH for the reactions is 9 (Means and Feeney, 1971). 
Bis diazonium ions can be used to crosslink proteins . 
Hapten-Protein Conjugates 
Hapten-protein conjugates are used to produce antibodies in 
anima ls. Choice of protein is based on cost, availability, and 
abi lity to elicit anti~enic response in the host animal. Hemocyanins, 
high molecular weight, copper-containing proteins, isolated from 
invertebrates are frequently used for this purpose. Haptens may have 
to be modified to introduce reactive groups or spacer arms prior to 
conjugation. Selection of methods for conjugation depends upon type 
of hapten and protein stab il ity (Kabakoff, 1980). In preparation of 
hapten-enzyme conjugates mild procedures are used to minimize loss of 
enzymic activity. It is advantageous to use different procedures for 
synthesis of hapten-protein and hapten-enzyme conjugates. Heterology 
of hapten conjugates improves sensitivity of immunoassays by 
increasing competition for free antigen (Va nWeeman and Schuurs, 1975). 
Antibodies specific for haptens are sensitive to hapten-protein 
linkage. Heterology can be achieved by using two different, but 
similar haptens; bridge heterology, using two methods for hapten 
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linkage to the same protein functional group; or site heterology, 
attaching haptens to different sites on the protein. 
The type of reaction used for coupling depends on the chemical 
nature of the hapten. Methods used to link haptens containing acidic 
groups (natural or introduced chemically ) include mixed anhydide 
reactions, carbodiimide and N-hydroxysuccinimide ester methods. 
Periodate cleavage and maleimide compounds are two-step linking 
procedures commonly employed for synthesis of hapten-protein complexes 
(Kabakoff , 1980). 
Penicillin-Protein Conjugates 
Reactions of peni~illin with proteins were initiated in the early 
1960 is for studying penicillin allergies (Williams and Chase, 1967) . 
Primary methods for formation of penicillin-protein conjugates are 
acylation of protein amino groups and disulfide bonds with cysteine. 
Penicilloyl conjugates (Figure 5) are formed at alkaline pH by 
reaction with protein amines, primarily lysine and are believed to be 
primarily responsible for human allergic response to penicillin. 
Benzylpenicillin is first converted to penicillanic acid which is 
used to prepare penicilloyl-protein conjugates at pH 11 .0 in 1 M 
carbonate buffer (Williams and Chase, 1967). Penicilloyl conjugates 
can also be synthesized by a similar procedure reacting penicillin -G 
directly with protein (Brown and Swaisgood, 1982). 
Penicillenate - protein conjugates are formed at neutral pH (Figure 
5). Free amine groups are blocked to inhibit formation of penicilloyl 
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(Williams and Chase , 1967). Penicillamine can also be conjugated to 
proteins via a disulfide linkage (Fi gure 5). 
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Figure 5. Chemical structures of penicillin bound to protein: 
(a) penicilloyl; (b) penicillenate and (c) penictilamine. 
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METHODS AND MATERIALS 
Preparation of Antibiotic-Protein Conjugates 
Penicillin and ampicillin were attached via the B-lactam ring to 
free amine groups on proteins (Brown and Swaisgood, 1982; Williams and 
Chase, 1967). It was necessary to use acid to adjust pH of the 
protein solution to pH 9.6 when using pH 10.4 sodium carbonate buffer 
(l.O M). Addition of acid to highly concentrated protein solution 
caused precipitation of some protein which decreased yield; therefore, 
1 .0 M sodium carbonate buffer was adjusted to pH 9.6 prior to addition 
of protein. Use of sodium or potassium salts of antibiotic rather 
than penicillin-HCl probably necessitated the pH change. In the final 
step samples were dialyzed against deionized H20 using either dialysis 
tubing or an ultrafiltration cell with 10,000 dalton exclusion 
membrane. This decreased laboratory time and dialysis using 
ultrafiltration membranes is as rapid as gel filtration. The 
protein-antibiotic conjugates prepared; penicillin-G-bovine gamma 
globulin (Pen-BGG), penicillin-G-rabbit serum albumin (Pen-RSA), and 
ampicill in-bovine gamma globulin (AM PC-BGG), were used in cross 
reactivity studies with anti-APA antibodies. 
Preparation of APA-Protein Conjugates 
Two procedures were used to prepare conjugates of 
6-aminopenicillanic acid (APA) and protein used for antibody 
production. Diazonium derivatives of APA were used for attachment to 
bovine gamma globulin (BGG) , and a sod ium periodate procedure was used 
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to attach APA to egg white albumin (ova lbu min ) (OVA ) via its 
carbohydrate moiety. 
Diazonium ions react with histidine, tyrosine, and lysine 
residues of proteins at alkaline pH (Means and Feeney, 1971; Williams 
and Chase , 1967). Procedures of Cignarella et al. (1962) and McMilla n 
and Stoodley (1968) for synthesis of 6- chloropenicillanic acid and 
6-bromopenicillanic acid were modified for synthesis of a diazonium 
intermediate to react with BGG. 
6-Chloropenicillanic acid is synthesized from APA with HCl and 
sodium nitrite at 0°C. In the proposed mechanism, 6-diazopenicillanic 
acid is converted to 6-chloropenicillanic acid with diazonium ions as 
an unstable intermediate (Sheehan et al ., 1977; McMillan and Stoodley , 
1968 ; Cignare11a et al ., 1962). 
-Nz 
Equation l . Synthesis of 6-chloropenici llanic acid. 
H H Cltts 
'0 N_;c 
COOH 
In preparation of conjugates, 400 mg APA was suspended in 40 ml 
distilled water, 140 ml methanol, and 20 ml HCl at 0°C . ~lhile 
stirring 2.073 (0.03m) sodium nitrite was added and held for 30 min. 
The reactio n mixture was added dropwise to l .0 g BGG in 20 ml 0. 13 M 
NaCl and 0.16 M boric acid buffer (pH 9.0). The pH was adjusted to 
9.0 with 0.5 N NaOH and held for l h. Following dialysis the 
conjugate was lyophilized and stored at -20°C . 
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Sodium periodate (NaI04 ) cleaves vicinal glycols of carbohydrate 
moieties forming dialdehydes. Amines can then be coupled by reductive 
alkylation using sodium borohydride (Kabakoff, 1980). 
b NalO, , (-; 6-APA 
HO OH O O 
)-o) 
NaBH1. " 
N 
I 
PA 
Equation 2. Sodium periodate method of attaching APA to 
glycoproteins. 
This procedure can be used to attach haptens with free amines to 
glycoproteins, crosslink glycoproteins to other proteins, or attach 
carbohydrates to proteins. 
Modification of NaI04 procedures by Nakane and Kawai (1974) for 
peroxidase-antibody conjugates and adenosine-protein conjugates (Lauer 
and Erlanger, 1974) were used to produce APA-OVA conjugates. This 
procedure was also used to attempt attachment of horsecrab hemocyanin 
to APA. 
Ovalbumin (500 mg) was dissolved in 20 ml 0. lM NaI04 and stirred 
in the dark for 30 min at 4°C, after which 200 µl of ethylene glycol 
was added and stirred for 30 min. Two hundred fifty milligrams of 
APA dissolved in 0. 15 M NaCl and 0.01 M MgCl buffer (adjusted to pH 
9.0 with 3% K2co2.) was added dropwise to protein solution. The pH 
was adjusted to 9.0 and held at 4°C for 1 .5 h. Sodium borohydride 
(250 mg/2 ml H20) was added dropwise and the reaction mixture was 
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refrigerated overnight . Followi ng dialysis the protein - hapten complex 
was dialyzed, lyophilized and stored at -20°C. 
Determination of Bound Antibiotics 
Bound haptens with ultraviolet (UV) absorbances can be determined 
by comparing spectra of conjugates to free protein and free hapten 
(Garvey et al., 1977). UV spectra of l.O or 2.0 mg per ml solutions 
of penicillin, ampicillin, BGG and antibiotic protein conjugates were 
obtained using a Beckman DU8-B spectrophotometer interfaced to a 
Textronics computer for data collection and storage. By comparison of 
non-overlapping maximum absorbances of haptens and protein solutions 
to conjugates, concentrations of each were calculated utilizing a 
computer program (Appendix I). 
Preparation of Antibodies 
Time for production of useful concentration of antibodies by 
rabbits is affected by the number of haptens attached to the protein 
carrier, protein used as the carrier, and also can vary greatly 
between rabbits (Odell and Franchimont, 1983). Several methods of 
inject i ons and schedules for antibody production have been suggested, 
but due to antigen and animal variability no "best" procedure can be 
determined (Garvey et al., 1977; Odell and Franchimont, 1983 ) . 
APA-OVA and APA-BGG conjugates were used as antigens for the 
production of antibodies in rabbits. Injection schedules and dosages 
were varied throughout the project . The procedure which proved most 
successful follows . For initial injections, hapten-protein conjugates 
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were diss olved in PBS buffer, which was emulsified one to one with 
Freud's complete adjuvant with a· final conjugate concentration of 25 
mg/ml emulsion. One milliliter emulsion was injected intramuscularly 
at 5-6 sites. A 2 mg conjugate/ml emulsion of one part conjugate in 
buffer and one part Freud's incomplete adjuvant was used for boosting 
injections. One milliliter of emulsion was injected intramuscular and 
subcutaneous at several sites. The boosting injections were given 2 
weeks after initial injection. Serum was collected and checked for 
titer 10 days after an injection. 
Titer of the antibody against the antigen was determined using 
Ouchterlony gel diffusion plates. A 1% agarose gel was prepared with 
3% polyethylene glycol incorporated into the gel to enhance bands of 
precipitation (Harrington et al., 1971; Wallenborg and Andersson, 
1978). Doubling dilutions of a starting solution of l mg protein or 
conjugate per ml tris barbituate buffer (TBS) were used for antigens 
in outer wells. Ten microliters were added to each well. 
Purification of Antibodies 
Affin ity chromatography has been used to isolate antibodies to 
specific antigens (Brown and Swaisgood, 1982; Heth and Brown, 1983). 
An affinity column for isolation of anti-APA immunoglobulins was 
prepared by attaching APA to thioester-derivatized glass beads (Brown 
et al., 1979). Thioester-derivatized glass beads attach to compounds 
via free amines. Penicillin-protein conjugates were used in preparing 
an affinity column by this method. APA was attached directly to 
thioester-derivatized glass beads (Figure 6). 
I I 
0 0 HO 0 OH 
I I I II 11 11 I H H 
-O-Si-O-S1 -(CH) -N-C _(CH ) -c-s-rcH ) -c -Nn~ : s 
I I 23 ~ 22 ~ 2z  
0 0 N I I 
0 ,,' H 
COOH 
Figure 6. Chemical structure of APA covalently bound to thioester-
derivatized glass beads used for affinity columns. 
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Two hundred seventy-five milligrams of APA were dissolved in 10 
ml O.OlM phosphate buffered saline (0 . 15 M NaCl, pH 7.5 ) (PBS) , to 
which 5.5 g of thioester-derivatized glass beads were added and 
degassed for 30 min. The beads in solution were then mixed using a 
shaker overn ight at 4°C. 
Ten centimeter columns with an interior diameter of l cm were 
filled with 6 ml of APA-thioester glass beads and equilibrated with 
PBS. Serum (l or 0.5 ml) was allowed to filter into the beads, and 
then mi xed through the column using a pasteur pipette. After addition 
of approximately l ml of degassed PBS to remove any air pockets, the 
column was held at room temperature for 1-2 h. 
Affinity columns using glass beads have very rapid flow rates, 
therefore if the serum is not allowed to stand in the column the total 
exposure time of antibodies to antigen is only 5 to 10 min. 
Incorporating a holding step into the procedure increased the amount 
of specific antibody obta ined. This would not be necessary if larger 
columns with slower flow rates were used. 
A peristaltic pump adjusted to maintain a flow rate of about l .5 
ml/per min was used. After elution of the non-binding serum 
components from the column, antibodies were eluted using 0. l M acetic 
acid. Decrease in pH interferes with antigen-antibody bonds. Peaks 
conta ining antibodies were collected and diluted with an equal volume 
of 0. l M sodium carbonate to increase the pH. The so lut ion of 
antibodies was dialyzed, lyophil ized and stored at -20 °C . 
Affinity columns for isolation of anti-penicillin an d 
anti - ampicillin antibod ies were prepared by attaching Pen-RSA or 
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AMPC-BGG to thioester-derivatized glass beads by the above procedure 
except 25 ml of a 10 mg antibiotic-protein conjugates per l mi PBS 
were added to 5.5 g beads. 
Affinity columns were used repeatedly without appreciable loss of 
binding capacity and rinsed with 25 ml of 4 M urea (filtered through 
0.45 µm filters) after 3 or 4 uses to remove adhered protein. Elution 
profiles were monitored at 280 nm using a Beckman DU8-B 
spectrophotometer connected to a Textronic computer which plotted and 
stored the data (Appendix II). 
Affinity Purification of Antibodies with OTT 
Antibody avidity is a prime factor in the sensitivity of enzyme 
immunoassays. It has been reported that exposure of antibodies to 
dithiothreitol (OTT) increases avidity by cleaving disulfide bonds 
which give immunoglobulins their characteristic shape and allows for 
free rotation of both immunoglobin binding areas (Thompson and 
Jackson, 1984). OTT was added to 500 µl anti -APA sera to a final 
concentration of 2 mM and held at room temperature for l .0 h (Reidler 
et al., 1982). The antibodies were isolated using APA attached to 
thioester -derivatized glass beads. Anti-APA antibodies purified from 
500 µl untreated serum were used for comparison. Antibody peaks were 
collected and protein content was determined by Bio-Rad protein 
assays (B io- Rad Lab., Richmond, CA). 
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APA-Enzyme Conjugates 
Hapten-enzyme conjugates were prepared by three methods. 
Penicillin-enzyme conjugates was synthesized by a carbodiimide 
procedure (Brown and Swaisgood, 1982). APA was bound to HRP using 
modified periodate carbodiimide, and fluorodinitrobenzene (FDNB) 
periodate procedures (Brown and Swaisgood, 1982; Lauer and Erlanger, 
1974; Nakane and Kawai, 1974 ) . 
HRP (200 mg) was dissolved 10 ml 0. 05 M NaI04 in PBS and was 
stirred, protected from light, for l hat room temperature. Ethylene 
glycol (200 µl) was added and stirred for 1 h. The solution was then 
dialyzed at 4°C in 0.01 M sodium carbonate buffer (pH 9. 5). Next 200 
mg APA was added and stirred at 4°C until dissolved. Then 200 mg 
sodium borohydride in 1 ml H2o was added dropwize . The reaction was 
held overnight prior to dialysis. 
In preparation of FDNB-HRP conjugates, 200 mg HRP was dissolved 
in 10 ml 0.3 M sodium carbonate buffer to which 4 ml of a l percent 
solution of FDNB in absolute ethanol was added . After l h of mixing, 
10.0 ml of 0.05 M NaI04 was added, held at room temperature and 
protected from light for l h. Ethylene glycol (100 µl) was added and 
mixed for l h prior to dialysis against 0.01 M sodium carbonate buffer 
(pH 9. 5) . Next 200 mg APA was added and mixed at room temperature for 
2-3 h. The reaction was cooled to 4°C and 200 mg sodium borohydride 
in l ml sodium carbonate buffer was added. After 12-16 h the protein 
solution was dialyzed and lyophylized. 
The carbodiimide used to attach HR P-APA was l-ethyl-
3-(3-dimethylaminopropyl )ca rbodii mide hydrochlor i de (EDC) . HRP (100 
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mg) was dissolved in PBS buffer adjusted to pH 4.75. EOC (190 mg) and 
250 mg APA were added in that order and stirred for 1 . 5 h at room 
temperature. The solution was then dialyzed to remove any unbound APA 
and lyophilized . HRP-PEN conjugates were prepared by the above 
procedure using 350 mg penicillin-G. 
Enzymic activities were compared using 1 .4 mM m-phenylenediamine 
in 2.8 mM hydrogen peroxide as substrate (Brown and Swaisgood, 1982). 
Absorbance maximum of 500 nm was determined by UV scan of substrate 
with enzyme after color had developed for 10 min. APA-enzyme 
solutions were prepared by adding 25 mg conjugate to 25 ml PBS. After 
stirring for severa l hours at 4°C the samples were · filtered through 
gla ss fiber filters to remo ve insoluble particles. 
Bio-Rad protein assays were used to determine protein content of 
enzyme solutions after filtration. Three milliliters of substrate and 
75 µl enzyme solutions were used for the assay. Change in absorbance 
at 500 nm was recorded for 5 min at 5 s intervals using a Beckman 
OUB-B spectrophotometer interfaced with a Textronics computer. 
34 
RESULTS AND DISCUSSION 
APA-Protein Conjugates 
Both APA-conjugates resulted in production of anti-APA 
antibodies, but the APA-OVA conjugate was more desirable. APA-OVA 
conjugates dissolved readily in buffer leaving no particulate matter. 
Also, high titer antisera from rabbits injected with APA-OVA could be 
obtained 3-4 weeks after the initial injection, whereas it took 
several months to obtain a high titer from rabbit injected with 
APA-BGG. This could be due to several factors. APA-OVA could have 
more haptens attached per mole protein, and the number of haptens 
attached to protein influences antigenic response to haptens. Also 
BGG is a mammalian protein which is more closely related to rabbit 
serum proteins than OVA, an avian protein, and therefore less 
antigen ic in rabbits than OVA. Hemocyanin, a copper protein isolated 
from invertebrates, is commonly used to bind haptens for antibody 
production because of its high antigenicity (Garvey et al., 1977). 
Attempts to utilize horsecrab hemocyanin for conjugation to APA were 
unsuccessful due to its insolubility during conjugation procedures. 
Antibiotic-Protein Conjugates 
The number of antibiotics, penicillin-G and ampicillin, attached 
to proteins were determined spectrophotometrically (Beech, 1975; 
Appendix I). This procedure cannot be applied to 6-APA since it 
doesn 1 t have an absorbance band in t he UV -region. Figures 7 and 8 are 
UV - scans of l . 0 mg pen icil lin per 1 .0 ml methanol and l .0 mg 
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Figure 7. UV scan of penicillin (1 .0 mg/ml MeOH). Absorbance peaks 
are at 259 and 265 nm, and inflection points are 254 and 
268 nm. 
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Figure 8. UV-scan of penicillin (l.O mg/ml H20). 
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penicillin per 1.0 ~l water respectively . The peaks are sharper in 
methanol, but still distinguishable in water. Presence of bound Pen 
can be determined quantitatively using absorbance at 259 nm for 
penicillin and 279 nm for BGG by comparison with absorbances of the 
conjugate at these wavelengths (Figures 8, 9 and 10). Pen-BGG had 
about 95 moles Pen per mole of BGG. Antibiotic covalently linked to 
protein can be qualitatively determined by visual inspection of 
UV-scans. Figures 11 and 12 are ultra violet (UV) scan profiles of 
AMPC and AMPC-BGG. Inflections of the absorbance profile between 250 
nm and 270 nm are visual proof of bound AMPC. 
Effect of OTT on Anti-APA Antibodies 
Addition of OTT to serum did not improve binding of anti -APA 
antibodies and actually decreased quantity of antibody isolates. 
Protein analysis of antibody peaks showed a 25 percent decrease in 
protein (immunoglobul ins ) in serum exposed to OTT. Therefore addition 
of OTT does not improve avidity of anti-APA antibodies and would not 
be beneficial in EIA using these antibodies . 
Immunodiffusion Analysis of Antisera 
Ouchterlony (double diffusion-double dimension) technique was 
used to analyze anti -APA and anti-Pen antisera (Garvey et al.,, 1977). 
Reactivity of antisera to hapten-proteins conjugates and proteins used 
in this study were compared. Anti-APA-BGG serum reacted with BGG and 
APA - BGG but not with Pen-BGG, showing specificity had developed for 
APA -conjugate and specificity was diminishing for BGG (Figure 13). 
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Figure 9. UV-scan profile of BGG (1 mg/ml H20). 
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Figure 10. UV-scan of penicillin-BGG (l mg/ml H2o). 
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Figure 11. UV-scan of ampicillin (2 mg/ml PBS). 
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Figure 1 2. UV-scan of AMPC-BGG ( 2 mg/ml PBS). The absorbance 
inflections between 250 nm and 270 nm are visual proof of 
the presence of bound AMPC. 
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Figure 13. Ouchterlony immunodiffusion gel of anti-APA serum obtained 
from rabbits injected with APA-BGG. Antigens (1 mg/ml) in 
outer wells are 1) BGG, 2) Pen-BGG, 3) Pen-RSA, 4) APA-BGG, 
5) APA-OVA, and 6) OVA. 
43 
APA-OVA antiserum only caused bands of precipitation to OVA and 
APA-OVA (F igure 14). Level of antigen (l mg/l ml TBS) was not 
appropriate to initiate precipitate to hapten only. Pen-BGG antiserum 
(Figure 15) precipitates with BGG, Pen-BGG and APA-BGG. 
Ouchterlony immunodiffusion was also used to compare titers of 
hapten-proteins to proteins used for conjugates. Higher titer for 
hapten-protein than for uncoupled protein indicates development of 
antibody specificity for haptens . More than one band of precipitation 
or spurs indicate more than one antibody against the antigen . Narrow 
sharp precipitate bands indicate near equal concentrations of antigen 
and antibody and broader bands result from unequivalent 
concentrations . Figure 17 is the best example of this, as 
concentration of antibodies and APA-BGG become closer bands are more 
distinct (we ll s 3 and 4). This is also an indication of the molecular 
weight of antigens. In comparison of APA-BGG (Figure 17 ) and APA-OVA 
(Figure 18), bands of precipitation to APA-OVA were never as distinct 
as APA-BGG. The mol~cular weight of OVA is about 40,000 and BGG is 
150,000 which is approximately the same as immunoglobulin-G. Both 
an tisera have titers to the seventh doubling dilution, 0.015625 (no t 
shown) to APA-protein. Antigenicity to hapten-protein was increased 
above antigenicity to proteins used for conjugation. Bands of 
prec ipitation of APA antiserum to BGG were distinct to fifth doubling 
dilution (Figure 16). APA antiserum produced from APA-OVA only had 
bands of precipitat ion against OVA to the third doubling dilution 
(Figure 19). The high titer of APA-OVA serum for APA-OVA and not OVA 
indicated its increased specificity for APA (Figures 18 and 19). 
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Figure 14. Ouchterlony immunodiffusion gel of anti-APA serum obtained 
using APA-OVA as antigen. Antigens (1 mg/ml) in outer 
wells are l) BGG, 2) Pen-BGG, 3) Pen-RSA, 4) APA-BGG, 
5) APA-OVA and 6) OVA. 
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Figure 15. Ouchterlony immunodiffusion gel of anti-Pen serum obtained 
using Pen-BGG as antigen. Antigens (1 mg/ml) in outer wells 
are 1) BGG, 2) Pen-BGG, 3) Pen-RSA, 4) APA-BGG, 5) APA-OVA 
and 6) OVA. 
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Figure 16. Titer of anti-APA serum (APA-BGG antigen) against doubling 
dilutions of BGG in TBS. BGG concentrations in outer 
wells are 1) 1.0 mg/ml, 2) 0.5 mg/ml, 3) 0.25 mg/ml, 
4) 0.125 mg/ml, 5) 0.0625 mg/ml and 6) 0.03125 mg/ml. 
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Figure 17. Titer of anti-APA serum (APA-BGG antigen) against doubling 
dilutions of APA-BGG in TBS. APA-BGG concentrations in 
outer wells are l) 1.0 mg/ml, 2) 0.5 mg/ml, 3) 0.25 mg/ml, 
4) 0.125 mg/ml, 5) 0.0625 mg/ml and 6) 0.03125 mg/ml. 
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Figure 18. Titer of anti-APA serum (APA-OVA antigen) against doubling 
dilutions of APA- VA in TBS. APA-OVA concentrations in 
outer wells are l) 1.0 mg/ml, 2) 0.5 mg/ml, 3) 0.25 mg/ml, 
4) 0.125 mg/ml, 5) 0.0625 mg/ml and 6) 0.03125 mg/ml. 
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Figure 19. Titer of anti-APA serum (APA-OVA antigen) against doubling 
dilutions of OVA in TBS. OVA concentrations in outer 
wells are 1) 1 .O mg/ml, 2) 0.5 mg/ml, 3) 0.25 mg/ml, 
4) 0. 125 mg/ml, 5) 0.0625 mg/ml and 6) 0.03125 mg/ml. 
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Purification and Crossreact ivity of Antibodies 
Antigens cova lentl y linked to glass beads were used to isolate 
antibodies and to show antigenicity towards antibiotics . Isolation of 
antibodies to bound antigen verifies existence of specific antibodies 
and provides proof that newly developed conjugation methods were 
successful. 
APA affinity columns were used to verify presence of anti-APA 
antibodies (Figures 20 and 21). Presence of anti-penicillin 
antibodies from antiserum produced from Pen-BGG was verified using a 
Pen-RSA affinity column (Figure 22). Purified antibodies would aid in 
calibration of EIA because exact concentration of antibodies used 
could be determined and controlled. 
Avidity of APA-OVA antiserum to Pen and AMPC was determined using 
a Pen-RSA affinity column and a AMPC-BGG affinity column (Figures 23 
and 24). Ability to obtain purified antibodies on these columns from 
APA antiserum showed that antibodies were specific for the 
thiazolidine ring of penicillins. 
Figure 25 is the elution profile of Pen-BGG antiserum over a 
AMPC-BGG affinity column. Purified antibodies were obtained, but 
since BGG was used in preparation of antiserum and affinity column the 
extent of cross-reactivity based on penicillin cannot be distinctly 
shown. Although it is surmised that Pen antiserum would cross - react 
to AMPC to some extent. 
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Figure 20. Affinity purification of anti-APA antibodies from 
APA-BGG antiserum using APA affinity column. 
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Figure 21. Affinity purification of anti-APA antibodies from 
APA-OVA antiserum using APA affinity column . 
/\ 
t 
( 
~ 
ro 
N 
v 
w 
u 
z 
~ 
(D 
rY 
0 
(j) 
(D 
~ 
3.5 
3.0 
2.5 
2.0 j 
j 
1.5 I I 
I ! 
1 . 0 r I 
I 
0.5 I 
0.0 
-0 .5 L---i--_.__.._____._____.._...___.L_~___.____.._~_.___.____. 
0 5 10 15 20 25 30 35 40 45 50 55 60 65 
VOLUME Cml) 
53 
Figure 22 . Affinity purifi cation of anti-Pen antibodies from Pen-BGG 
antiserum using Pen-RSA affinity column. 
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Figure 23. Aff ini ty purification of anti-Pen antibodies from 
APA-OVA antiserum using Pen-RSA affinity column. 
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Figure 24. Affinity purification of anti-AMPC antibodies from 
APA-OVA antiserum using AMPC-BGG affinity column. 
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Figure 25. Affinity purification of anti AMPC-BGG antibodies from 
Pen-BGG antiserum using AMPC-BGG affinity column. 
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Enzyme-Hapen Conjugates 
The relative activities of APA-HRP conjugates are shown in 
Table 2. Combination of NaI04 conjugation and the FDNB amine-blocking 
procedures resulted in total inactivation of HRP and also greatly 
decreased HRP solubility. Although similar procedures have previously 
been used successfully, modification of the procedure would be needed 
for use with APA conjugation. NaI04 procedure also caused a decrease 
in enzymic activity, which is expected, but 41 % loss of activity is 
larger than desired . Further modification of this enzyme-hapten 
conjugation procedure to decrease activity loss would be needed to 
make the process economically feasible for EIA. EDC coupling 
procedure showed increase in enzymic activity . The mild procedure 
obviously did not inhibit enzymic activity and dialysis during the 
procedure may have removed any inhibiting substances that may have 
been present in the grade of HRP used. Crosslinking of HRP to HRP may 
have also affected activity of the enzyme. 
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Table 2. Relative activities of enzyme conjugates . 
Concentration % of Uncoupled HRP 
Enzyme µg/7 5 µ 1 llAbsorbancea Activity 
HRP 20.55 14.5xl0 -5 100 
HRP -APA 20.625 17.9x l0 -5 123 
( EDC-Procedure) 
HRP -A PA 30.3 8 .6xl0 -5 59 
(NaI04 Procedure) 
DNB-HRP -APA 2.25 0 0 
(NaI04 Procedure) 
a) LI Absorbance is change in absorbance per s at 500 nm. 
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CONCLUSIONS 
Methods for preparation of APA-conjugates and antibodies needed 
for EIA have been developed. APA-OVA synthesized by periodate 
procedure is the preferred conjugate for production of APA-specific 
antibodies in rabbits, but APA-BGG should be used for antibody 
production if a periodate procedure is used in the assay for 
conjugation of APA to enzymes. Using a different protein (OVA) in 
conjugating APA by the diazonium procedure could increase 
antigenicity. Different methods of conjugation for APA-protein and 
APA-enzymes are desired because antibodies are antigenic toward 
protein-hapten linkage which decreases sensitivity in EIA. 
APA-HRP prepared by EDC procedure is the preferred enzyme for EIA 
because enzymic activity is retained. It would be advantageous to 
refine the method by using an enzyme with protected amines or carboxyl 
groups to prevent protein-protein crosslinking during the procedure. 
FDNB for blocking amines affects enzymatic activity and 
(t-buty loxycarbonyloxyimi no)2-phenylacetonitrile (BOC) used to protect 
am in e groups on proteins decreased protein solubility too greatly to 
be used. It is suggested that the EDC procedure for hapten-enzyrne be 
modified by first attaching protein to thioester-derivatized glass 
which would bind free amines and prevent enzyme-enzyme linkage after 
addition of EDC and hapten. Unbound hapten and crosslinked haptens 
could easily be removed by washing the beads. Hapten-HRP could then 
be released by hydroxylamine cleavage of the thioester bound on glass 
beads. Cross -linked enzymes utilized for EIA would decrease 
sensitivity of the assay and make it difficult to calibrate. 
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Antibodies produced against APA are antigenic toward the 
thiazolidine ring of penicillins as shown by their affinity towards 
ampicillin and penicillin. Anti-APA antibodies should therefore be 
antigenic towards other semisynthetic penicillins because APA i s 
usually used in their synthesis. 
The goal to develop an EIA for analysis of a class of compounds 
is different than the goal of most EIA which desire specificity for 
particular drugs or hormones. Determination of the presence of 
S- lactam antibiotics is wanted and identification of the antibiotic is 
not needed. 
Development of an antibiot1c EIA for use in milk is complicated 
by the complexity of milk. Methods of conjugation of penicillin and 
APA to protein in this laboratory have concentrated on attachment via 
the s-lactam ring. APA was attached to proteins via its free amine 
and penicillin conjugates are penicilloyl linkages, i.e. attachment to 
protein lysine by cleavage of the lactam ring at alkaline pH . 
Penicilloyl (Figure 5) is cons idered the predominant protein 
attachment which causes allergic reaction, but penicillenate (Figure 
5) a disulfide linkage to protein by cleavage of the thiazole ring 
also occurs spontaneously at neutral pH. The pH of fresh milk is 
6.65. Sulfhydryl proteins in mi lk (K-casein and S-lactoglobulin) may 
bind some penicillin. Antibodies produced against penicilloyl linkage 
may not be antigenic towards penicillinate due to structural change. 
All penicillin in milk would not be bound in this form, but some would 
still cause interference in EIA. This probably would not be evident 
in initial laboratory studies, because penicillin spiked milk would 
typically not be held for several days prior to assaying for 
penicillin. 
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The potential for anti-APA antibodies to be used to detect 
B-lactam antibiotics was shown. The methods for antibody production 
and conjugates synthesized can now be used to develop EIA procedure 
for APA and B-lactam antibiotics. 
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Appendix I 
Computer Program: UV-Scans 
4 PAGE 
5 GOSUB 110 
6 END 
8 PAGE 
9 GOSUB 210 
10 END 
12 PAGE 
13 GOSUB 1190 
14 END 
16 PAGE 
17 W=32 
18 GOSUB 1070 
19 END 
20 PAGE 
21 W=l 
22 GOSUB 1070 
23 END 
24 PAGE 
25 GOSUB 1360 
26 END 
28 PAGE 
29 Q9=32 ' 
30 GOSUB 1360 
31 END 
32 PAGE 
33 Q9=41 
34 GOSUB 1360 
35 END 
36 PAGE 
37 GOSUB 2020 
38 END 
100 1 NPUT H 
110 REM ** INITIALIZE ** 
120 INIT 
130 W=32 
140 CALL "RATE",9600,l,2 
150 G$= 1111 
160 G::O 
170 DIM Y(2000),X(2000) 
180 PAGE 
190 Rl=l20 
200 KETURN 
210 REM ** ENTER PARAMETERS AND RUN ** 
220 GOSUB 110 
230 PRINT "JJJJJDATE •••.•••.•..••••• II; 
240 INPUT U$ 
250 PRINT 
260 PRINT "Enter 'H' (l=scale 0 to 4)"; 
270 INPUT H 
280 PR INT 
290 1-'RINT "Now push STOP twice, then RUN, then the file" 
300 PRINT "number where the data should be saved followed" 
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310 PRINT "by ENTER. II 
320 I=l 
330 !NPUT @40 : X$ 
340 PRINT @40: 11 F11 
350 INPUT @40:Z$ 
360 1$=SEG(Z$,9,6) 
370 l=VAL(T$) 
380 K$=SEG(Z$,16,6) 
390 K=VAL(R$) 
400 P$=SEG(Z$,23,4) 
410 K2=VAL(P$) 
420 GOSUB 660 
430 rOR I=l TO 4000 
440 INPUT @40 : Y$ 
450 Y(I)=VAL(Y$) 
460 IF I<>l THEN 480 
470 MOVE @32:T-R2*I/Rl,Y( I ) 
480 DRAW @32:T-R2*I/Rl,Y(I) 
490 IF T-R2*I/Rl<R+l THEN 510 
500 NEXT I 
510 F$=SEG(Z$,7, 2) 
520 F=VAL(F$) 
530 lF F=l THEN 550 
540 IF F<>2 THEN 580 
550 PRINT "GGGGGGGGThis file contains a program! " 
560 PRINT "Enter a new file number . 11 ; 
570 !NPUT t-
580 FIND F 
590 WRITE @33: X$ 
600 WRITE @33:Z$ 
610 FOR J=I-1 10 1 STEP -1 
620 WRITE @33:T-R2*J/Rl,Y(J) 
630 NEXT J 
640 PRINT 11 GGGGGGGGGGGGGGGGGGGGGGG 11 
650 KETURN 
660 KEM ** PLOT ** 
670 PAGE 
680 V1EWPORT 40,120,20,80 
690 WINDOW R,T,-0.5,4*H 
700 AXIS @W : 5,0.5,R,-0.5 
710 MOVE @W:R,4*H 
720 Z=O 
730 DRAW @W:T,4*H 
740 URAW @W:T,-0.5 
750 MOVE @W:O,R 
760 GOSUB 980 
770 Al=O. 6 
780 FOR J=R TOT STEP (T-R)/5 
790 MOVE @W:J-l+Al,-0.5-0.3*H 
800 PRINT 11 H11 ; 
810 PRINT @W: USING 11 3D 11 :J 
820 NEXT J 
830 rOR J=O TO 4*H STEP 0.5 
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840 MOVE @W:R-O.l*(T-R),J-0.05 
850 1F W<>32 THEN 870 
860 PRINT @32:"HH"; 
870 PRINT @W: uTING "2D.1D" :J 
880 NEXT J 
890 MOVE @W:(T-R)/2+R-15,-0.5-0.6*H 
900 PRINT @W:"WAVELENGTH (nm)" 
910 lF W=32 THEN 970 
920 MOVc @W:R-0.15*(T-R),1.75*H 
930 PRINT @W,25:90 
940 PRINT @W:"HHHHHHHHHABSORBANCE"; 
950 MOVE @W:-5.5,-0.11 
960 PRINT @W,25:0 
970 KETURN 
980 MOVE @W:5,-0.5 
990 KDRAW @W:U,0.15*H 
1000 MOVE @W:l0,-0.5 
1010 KDRAW @W:U,0.15*H 
1020 FOR I=0.5 TO 4*H STEP 0.5 
1030 MOVE @W:O,I 
1040 KDRAW @W:0.4,0 
1050 NEXT I 
1060 KETURN 
1070 REM ** PLOT DATA ** 
1080 PAGE 
1090 PKINT "JJJJJJEnter 1 H' (1 =Oto 4 scale). 11 ; 
1100 1NPUT H 
1110 PAGE 
1120 GUSUB 660 
1130 FOR I=l TO (T-R)*(Rl/R2)-10 
1140 1F I<>l THEN 1160 
1150 MOVE @W:X(l), Y(l) 
1160 URAW @W:X(I),Y(I) 
1170 NEXT I 
1180 KETURN 
1190 REM ** LOAD DATA FROM TAPE ** 
1200 GOSUB 110 
1210 PRINT "JJWHICH FILE ON TAPE? 11 ; 
1220 lNPUT Fl 
1230 FIND Fl 
1240 KEAD @33:X$ 
1250 KEAD @33:Z$ 
1260 1$=SEG(Z$,9,6) 
1270 i=VAL(T$) 
1280 K$=SEG(Z$,16,6) 
1290 K=VAL(R$) 
1300 P$=SEG(Z$,23,4) 
1310 K2=VAL(P$) 
1320 FOR I=l TO (T-R)*(Rl/R2)-5 
1330 KEAD @33:X(I),Y(I) 
1340 NEXT I 
1350 KETURN 
1360 KEM ** CALCULATE AND PRINT PARAMETERS ** 
70 
1370 PRINT "JJJSTARTING FILE NUMBER ••• II; 
1380 1 NPUT tl-9 -
1390 PRINT "JENO ING r ILE NUMBER ••••• 11 ; 
1400 !NPUT 1:9 
1410 FOR L=B9 TO E9 
1420 Fl=L 
1430 uOSUB 123U 
1440 A=INT(4*R2/Rl) 
1450 t=INT(l3*R2/Rl) 
1460 lF (E-A)/2<>INT((E-A)/2) THEN 1480 
1470 t=E+l 
1480 M=O 
1490 FOR I=l TO INT(7.5*R2/Rl) 
1500 !F Y(I)<M THEN 1530 
1510 M=Y(l) 
1520 B=l 
1530 NEXT I 
1540 M=O 
1550 FOR I=INT(l.5*R2/Rl) TO R2*T 
1560 lF Y(I)<M THEN 1590 
1570 M=Y(I) 
1580 U=l 
1590 NEXT I 
1600 C=B+0.5*(0-B) 
1610 1F (C-A)/2<>INT((C-A)/2) THEN 1630 
1620 C=C+l 
1630 Al=O 
1640 FOR l=A TO c 
1650 Al=Al+Rl/R2*(Y(I+l)+Y(I)) 
1660 NEXT I 
1670 Al=Al*0.5 
1680 A2=0 
1690 FOR I=C TO t 
1700 A2=A2+Rl/RL*(Y(I+l)+Y(l)) 
1710 NEXT I 
1720 A2=A2*0.5 
1730 ::i=O 
1740 ::i=Y(A)+Y(C) 
1750 FOR l=A+l TO C-1 
1760 ::i=S+2*Y(I) 
1770 NEXT I 
1780 FOR I=A+2 TO C-2 STEP 2 
1790 ::i=S+2*Y(I) 
1800 NEXT I 
1810 A3=S/(R2/Rl*3) 
1820 ::i=O 
1830 ::i=Y(C)+Y(E) 
1840 FOR l=C+l TO E-1 
1850 ::i=S+2*Y(I) 
1860 NEXT I 
1870 FOR l=C+2 TO £-2 STEP 2 
1880 ::i=S+2*Y(l) 
1890 NEXT I 
71 
1900 A4=S/(RL/Rl*3) 
1910 1-'RINT @Q9: "JJSAMPLE NO. II ;S$; II FILE NO. II ;F 
1920 1-'RINT @Q9:"0 VOLUME ABSORBANCE AREA" 
1930 1-'RINT @Q9: USING 1980:A/R2*Rl,Y(A) 
1940 1-'RINT @Q9: USING 1990:B/R2*Rl,Y(B),Al,A3 
1950 1-'RINT @Q9: USING 1980:C/R2*Rl,Y(C) 
1960 PRINT @Q9: USING 1990:0/R2*Rl,Y(D),A2,A4 
1970 PRINT @Q9: USING 1980:E/R2*Rl,Y(E) 
1980 1MAGE 3X,2D.2D,5X,2D.20 
1990 1MAGE 3X,2D.2D,5X,2D.20,5X,20.30,5X,20.3D 
2000 NEXT L 
2010 KETURN 
2020 KEM ** PRINT DATA FROM TAPE ** 
2030 PAGE 
2040 PK I NT "TYPE I 32 I FOR SCREEN OR I 41' FOR PRINTER. II 
2050 lNPUT lJ9 
2060 PAGE 
2070 S$=SEG(Z$,28,2) 
2075 1-'RINT @Q9:"L" 
2080 PR INT @Q9 : "fi le #. . • • • • . • • "; F 1 
2090 PRINT @Q9:"Slit # ••••••••• ";S$ 
2100 PRINT @Q9 : "Points/min ••••• ";Rl 
2110 PRINT @Q9:"nm/min ••••••••• ";R2 
2120 PRINT @Q9: "Low Wavelength. ";R 
2130 PRINT @Q9:"High Wavelength ";T 
2140 PRINT @Q9: 
2150 PRINT @Q9:" nm Absorbance" 
2160 PRINT @Q9: 
2170 FOR I=l TO (T-R)*(Rl/R2)-10 
2180 PRINT @Q9: USING "3d.ld,2x,2d.4d":X(I),Y(I) 
2190 NEXT I 
2200 t<ETURN 
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4 PAGE 
5 GOSUB 1000 
6 END 
8 PAGE 
9 GOSUB 2000 
10 END 
12 PAGE 
13 GOSUB 5000 
14 END 
16 PAGE 
17 W=32 
18 GOSUB 4000 
19 END 
20 PAGE 
21 W=l 
22 GOSUB 4000 
23 END 
24 PAGE 
25 GOSUB 6000 
26 END 
28 PAGE 
29 Q9=32 
30 GOSUB 6000 
31 END 
32 PAGE 
33 Q9=41 
34 GOSUB 6000 
35 END 
36 PAGE 
37 GOSUB 7000 
38 END 
180 !NPUT H 
1000 KEM ** INITIALIZE ** 
1010 !NIT 
1020 W=32 
1025 CALL "RATE",1200,0,2 
1030 (j$="" 
1040 G=O 
1050 UIM Y(lOOO) 
1060 PAGE 
1070 PRINT "WHAT I~ H (try l)? "; 
1080 !NPUT H 
1499 RETURN 
2000 REM ** ENTER PARAMETERS AND RUN COLUMN ** 
2005 (j0SUB lOOU 
2010 PRINT 11 JJJJJDATE •••••••••••••••• II; 
2020 lNPUT U$ 
2030 PRINT 11 JFILE NUMBER ••••••••• 11 ; 
2040 1 NPUT r -
2045 lF F=l THEN 8 
2050 PRINT 11 JSAMPLE NUMBER ••••••• II; 
2060 lNPUT ~$ 
2070 PRINT UJSAMPLE SIZE ••••••••• II; 
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2080 INPUT :) 
2090 PRINT 11 JFLOW RATE ...•.••.... 11 ; 
2100 !NPUT KT 
2110 PKINT "JREADINGS PER MIN ••• II. 
- , 
2120 !NPUT K2 
2122 PRINT 1'JRUN I IME •••••••••••• II; 2125 !NPUT 1-
2130 FIND F 
2132 GOSUB 300U 
2135 MOVt @32:0,0 
2140 FOR I=l TO T*R2 
2150 lNPUT @40:Xl,X2,Y(I) 
2155 URAW @32:I/R2*Rl,Y(I) 
2160 NEXT I 
2170 WRITE @33:0$ 
2180 WRITE @33:F 
2190 WRITE @33:S$ 
2200 WRITE @33:S 
2210 WRITE @33:Rl 
2220 WRITE @33:RL 
2230 WRITE @33 :T 
2240 FOR 1=1 TO T*R2 
2250 WRITE @33:Y(I) 
2260 NEXT I 
2270 PRINT "GGGGGGGGGGGGGGGGGGGGGGG" 
2499 RETURN 
3000 REM ** PLOT ** 
3010 lF W=l IHEN 3040 
3020 VIEWPORT 70,128,15,95 
3030 l:lO TO 305U 
3040 VItWPORI 40,120,20,80 
3050 WINDOW 0,5*INT((T*Rl+4.95)/5),-0.5,4*H 
3060 AXIS @W:5,0.5,0,-0.5 
3070 MOVE @W:0,-0.5 
3075 Z=O 
3080 FOR I=l TO 1 
3090 URAW @W:O+Z*4.35,-0.5+Z*H 
3100 URAW @W:5*INT((T*Rl+4.95)/5)-Z*4.35,-0.5+Z*H 
3110 URAW @W:5*INT((T*Rl+4.95)/5)-Z*4.35,(4-Z)*H 
3120 URAW @W:O+Z*4.35,(4-Z)*H 
3125 Z=Z+0.007 
3130 NEXT I 
3140 Al=-0.7 
3150 FOR J=O TO INT(T*Rl) STEP 5 
3160 lF J<lO THEN 3180 
3170 Al=-1.2 
3180 MOVE @W:J-l+Al,-0.5-0.3*H 
3200 PRINT "H"; 
3210 PRINT @W:J; 
3220 NEXT J 
3230 FOR J=-0.5 TO 4*H STEP 0.5 
3240 MOVE @W:-T*(Rl/2)/4.5,J-0.05 
3250 lF W<>32 THEN 3270 
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3260 r>RINT @32: "HH 11 ; 
3270 r'RINT @W: USING 11 20.lD":J 
3280 NEXT J 
3420 MOVE @W:T*(Rl/2),-0.5-0.6*H 
3430 PRINT @W: 11 HHHHHVOLUME (mL) 11 
3440 lf W=32 THEN 3530 
3450 MOVE @W:-T*(Rl/2)/3.75,l.75*H 
3460 PRINT @W,25:90 
3470 PRINT @W: 11 HHHHHHHHHABSORBANCE ( 280nm) 11 ; 
3480 MOVE @W:-5.5,-0.11 
3500 PRINT @W,25:0 
3530 t<ETURN 
3600 MOVE @W:5,-0.5 
3610 KDRAW @W:U,0.15*H 
3620 MOVE @W:l0,-0.5 
3630 KDRAW @W:0,0.15*H 
3640 FOR I=0.5 TO 4*H STEP 0.5 
3650 MOVE @W:O,I 
3660 KDRAW @W:0.4,0 
3670 NEXT I 
3680 KETURN 
4000 REM ** PLOT DATA ** 
4010 GOSU8 3000 
4015 Z=O 
4020 MOVE @W:O,O+Z 
4030 FOR I=l TO T*R2 
4040 URAW @W:I/R2*Rl,Y(I)+Z 
4050 NEXT I 
4055 Z=Z+O.Ol*H 
4060 t<ETURN 
5000 KEM ** LOAD UATA FROM TAPE ** 
5005 GOSUB 1000 
5010 PRINT 11 JJWHICH FILE ON TAPE? "; 
5020 INPUT Fl 
5021 PRINT 
5030 FIND Fl 
5040 KEAD @33:D$ 
5050 KEAD @33:F 
5060 KEAD @33:S$ 
5070 t<EAD @33:S 
5080 KEAD @33:Rl 
5090 KEAD @33:R2 
5100 KEAD @33:T 
5110 FOR l=l ro T*R2 
5120 t<EAD @33:Y(I) 
5130 NEXT I 
5140 t<ETURN 
6000 REM ** CALCULATE AND PRINT PARAMETERS ** 
6010 PRINT 11 JJJSTARTING FILE NUMBER ••• 11 ; 
6020 INPUT 89 
6030 PRINT 11 JENDING r ILE NUMBER ••••• 11 ; 
6040 lNPUT t9 
6050 FOR L=B9 TO E9 
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6060 Fl=L 
6070 GOSUB 5030 
6080 A=INT(4*R2/Rl) 
6090 t=INT(l3*R2/Rl) 
6095 IF (E-A) / 2<>INT((E-A)/2) THEN 6100 
6097 E=E+l 
6100 M=O 
6110 FOR I=l TO INT(7.5*R2/Rl) 
6120 lF Y(I)<M THEN 6150 
6130 M=Y(I) 
6140 B=I 
6150 NEXT I 
6160 M=O 
6170 FOR I=INT(7.5*R2/Rl) TO R2*T 
6180 IF Y(I)<M THEN 6210 
6190 M=Y(I) 
6200 U=I 
6210 NEXT I 
6220 C=B+0.5*(0-8) 
6230 !F (C-A)/2<>INT((C-A)/2) THEN 6250 
6240 C=C+l 
6250 Al=O 
6260 FOR I=A TO C 
6270 Al =Al+Rl/R2*(Y(I+l)+Y(I)) 
6280 NEXT I 
6290 Al=Al*0 .5 
6300 A2=0 
6310 FOR I=C TO t 
6320 A2=A2+Rl/R2* (Y(I+l)+Y(I)) 
6330 NEXT I 
6340 A2=A2*0.5 
6350 :S=O 
6360 :S=Y(A)+Y(C) 
6370 FOR I=A+l TO C-1 
6380 :s=S+2*Y(I) 
6390 NEXT I 
6400 FOR I=A+2 TO C-2 STEP 2 
6410 :S=S+2*Y(I) 
6420 NEXT I 
6430 A3=S/(R2/Rl*3) 
6440 :S=O 
6450 :S=Y(C)+Y(E) 
6460 FOR I=C+l TO E-1 
6470 :S=S+2*Y(I) 
6480 NEXT I 
6490 FOR I=C+2 TO E-2 STEP 2 
6500 :s=S+2*Y(I) 
6510 NEXT I 
6520 A4=S/(R2/Rl*3) 
6530 PRINT @Q9: 11 JJSAMPLE NO. 11 ;S$; 11 FILE NO. ";F 
6550 PRINT @Q9: 11J VOLUME ABSORBANCE AREA" 
6560 PRINT @Q9: USING 6610:A/R2*Rl,Y(A) 
6570 PRINT @Q9: USING 6620:8/R2*Rl,Y(B),Al,A3 
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6580 PRINT @Q9: USING 6610:C/R2*Rl,Y(C) 
6590 PRINT @Q9: USING 6620:0/R2*Rl,Y(D),A2,A4 
6600 PRINT @Q9: USING 6610:E/R2*Rl,Y(E) 
6610 lMAGE 3X,2D.20,5X,2D.2D . 
6620 lMAGE 3X,2D.20,5X,2D.20,5X,2D.3D,5X,2D.3D 
6630 NEXT L 
6640 t<ETURN 
7000 KEM ** PRINT UATA FROM TAPE ** . 
7005 PAGE 
7010 PKINT "JJWHICH FILE ON TAPE? "; 
7020 l NPUT F-1 
7021 PRINT 
7030 FIND Fl 
7035 PAGE 
7036 PRINT "TYPE 1 32' FOR SCf<EEN OR 1 41 1 FOR PR INTER." 
7037 lNPUT lJ9 
7040 l<EAD @33:0$ 
7050 KEAD @33:F 
7060 l<EAD @33:S$ 
7070 KEAD @33: S 
7080 KEAU @33 :Rl 
7090 t<EAD @33:R2 
7100 KEAU @33:T 
7101 PAGE 
7102 PRINT @Q9:"DATE ••••••••••• 11 ;0$ 
710 3 p R INT @Q 9 : II F I LE # ••••••••• II ; F 
7104 PRINT @Q9:"SAMPLE # ••••••• ";S$ 
7105 PRINT @Q9:"SAMPLE SIZE •••• ";S 
7106 PRINT @Q9:"FLOW RATE •••••• 11 ;Rl 
7107 PRINT @Q9: "READINGS/MIN ••• II ;R2 
7108 PRINT @Q9: "RUN I IME ••••••• II; T 
7109 PRINT 
7110 FOR I=l ro T*R2 
7120 KEAD @33:Y(I) 
7125 PRINT @Q9:60/R2*I/60*Rl,Y(I) 
7130 NEXT I 
7140 t<ETURN 
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